Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.
about
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchA Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Comparison of two methods for the analysis of CSF Aβ and tau in the diagnosis of Alzheimer's diseaseThe Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsShould interventions to treat or prevent Alzheimer's disease be tested in a population or as targeted treatment of highly selected study participants?PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders,Amyloid imaging in Alzheimer's disease: a literature review.Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies.Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease.Evolving Relevance of Neuroproteomics in Alzheimer's Disease.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.
P2860
Q24289435-C99C70C1-8B12-4725-B693-699C4B3EF622Q30235315-69250139-F196-4E1D-BAE1-74A193A146BAQ34987497-F35EB206-FAE7-4525-8B44-C5E210646477Q36165011-E3725ED4-5D31-46E2-A758-7F369AE74001Q37690944-BC561B3E-F694-4F57-89F8-FC62E62C7ABBQ37718557-07A48633-CD0B-4F33-B117-7C9A2C489A1EQ38243166-BCE9AF3B-4620-4554-B29A-1A0EF3EC7BEEQ38250091-23598483-B39D-4BA7-AE2E-9884A87B31E2Q38344088-177F6339-059A-4912-9FAE-24AC1F88073AQ38704916-B480DB00-C722-45B3-ACA1-9B4132038031Q38873321-9100D7D1-43DD-4D80-9495-2DF6D6F9E116Q50999408-104590AF-9937-4471-A7DE-6C6064358617Q51760905-5AC4D2C4-1AF7-4617-AD95-8B597A588218
P2860
Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Use of biomarkers and imaging ...... action and target engagement.
@en
Use of biomarkers and imaging ...... action and target engagement.
@nl
type
label
Use of biomarkers and imaging ...... action and target engagement.
@en
Use of biomarkers and imaging ...... action and target engagement.
@nl
prefLabel
Use of biomarkers and imaging ...... action and target engagement.
@en
Use of biomarkers and imaging ...... action and target engagement.
@nl
P2860
P1476
Use of biomarkers and imaging ...... action and target engagement.
@en
P2093
P2860
P2888
P356
10.1007/S12603-013-0003-1
P577
2013-01-01T00:00:00Z